Skip to Content

  • Search

View Additional Section Content

251 – A Phase II Trial of NCI Supplied Agent: Bevacizumab (rhuMAB VEGF) (NSC 704865, IND7921) for Recurrent Sex Cord-Stromal Tumors of the Ovary

Clinical Trial Categories

  • Rare Ovarian Cancer
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details